Senti Biosciences

Advancing synthetic immunology

Senti Biosciences develops programmable cell and gene therapies for patients with cancer and other incurable diseases using synthetic gene circuits.

Cell Design Labs

This biotherapeutics company develops programmable cell therapies for cancer patients by engineering immune cells with synthetic genetic circuits to improve precision and safety.

Synthetic biology-powered mRNA therapeutics

The company develops programmable mRNA therapies using synthetic biology genetic circuits to deliver precise treatments for patients with cancer and other complex diseases.

ArsenalBio

The company develops programmable T cell therapies for patients with solid tumours and autoimmune diseases.

Century Therapeutics

This biotechnology company develops induced pluripotent stem cell-derived therapies to treat patients with cancer and autoimmune diseases.

Synteny Biotechnology

The company develops generative AI platforms to design programmable protein therapeutics and precision immunology treatments for biotechnology researchers and pharmaceutical developers.

A2 Biotherapeutics

This company develops logic-gated T-cell therapies to treat patients with solid tumours by selectively targeting cancer cells while sparing healthy tissue.

Modulari-T Biosciences

This company develops modular immune receptors and delivery vehicles to create cell and gene therapies for patients with cancer and autoimmune diseases.